Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-12-25
2007-12-25
Saoud, Christine J. (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S350000, C530S399000
Reexamination Certificate
active
10785720
ABSTRACT:
Isolated omentin polypeptides that selectively express in omental fat tissue and methods for the use of the polypeptides. The polypeptides can be used in a method for modifying insulin action and/or glucose metabolism in an animal. The polypeptides can be used to promote glucose uptake by animal adipocytes and other cells, tissues, and/or organs. The polypeptides can also used to provide a therapeutic treatment for diseases of or related to glucose metabolism and adipose tissues. The polypeptides are also incorporated into diagnostic tests and testing kits for diagnosing or detecting a disease or condition involving animal tissue that contains, uses, or expresses the polypeptide in an animal suspected of having the disease or condition.
REFERENCES:
patent: 6146849 (2000-11-01), Pierce et al.
patent: 6342581 (2002-01-01), Rosen et al.
patent: 6478825 (2002-11-01), Winterbottom et al.
patent: 6635255 (2003-10-01), Bruck et al.
patent: 2002/0173635 (2002-11-01), Jacobs et al.
patent: 2003/0064412 (2003-04-01), Fischer et al.
patent: 2004/0044191 (2004-03-01), Fischer et al.
patent: 99/49033 (1999-09-01), None
patent: 99/60161 (1999-11-01), None
patent: 00/05367 (2000-02-01), None
patent: 00/66708 (2000-11-01), None
patent: 00/73454 (2000-12-01), None
patent: 01/16318 (2001-03-01), None
patent: 01/68848 (2001-09-01), None
patent: 02/068579 (2002-09-01), None
Yang et al.: cDNA Cloning, Genomic Structure, Chromosomal Mapping, and Functional Expression of a Novel Human Alanine Aminotransferase.Genomics, Mar. 2002; 79(3): pp. 445-450.
Kashiwagi et al.: In Vitro Insulin Resistence of Human Adipocytes Isolated From Subjects With Noninsulin-Dependent Diabetes Mellitus.J Clin Invest, Oct. 1983; 72(4): pp. 1246-1254.
Tsuji et al.: Human Intelectin Is a Novel Soluble Lectin That Recognizes Galactofuranose in Carbohydrate Chains of Bacterial Cell Wall.The Journal of Biological Chemistry, Jun. 2001, vol. 276, No. 26, pp. 23456-23463.
Lee et al.: Human Homologs of the Xenopus Oocyte Cortical Granule Lectin XL35.Glycobiology, 2001, vol. 11, No. 1, pp. 65-73.
Suzuki et al.: Molecular Cloning and Functional Expression of a Human Intestinal Lactoferrin Receptor.Biochemistry, 2001, vol. 40, pp. 15771-15779.
Komiya et al.: Cloning of the Novel Gene Intelectin, Which is Expressed in Intestinal Paneth Cells in Mice.Biochemical and Biophysical Research Communication, 1998, vol. 251, pp. 759-762.
Altschul et al.: Gapped Blast and PSI-Blast: A New Generation of Protein Database Search Programs.Nucleic Acids Research, 1997, Vo. 25, pp. 3389-3402.
Gong Da-Wei
McLenithan John
Shuldiner Alan
Yang Rongze
Saoud Christine J.
University of Maryland Baltimore
LandOfFree
Method of modifying glucose activity using polypeptides... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of modifying glucose activity using polypeptides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of modifying glucose activity using polypeptides... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3836230